ArticleResearch (Washington, D.C.)2023

Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy.

Chao Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.